Inulin prebiotic shows anti-inflammatory potential in obese people: RCT Three months of consuming chicory inulin led to significant decreases in fecal markers of inflammation in obese people, according to data from the Food4Gut randomized placebo-controlled trial.
Data published in the
European Journal of Nutrition indicated that 16 grams per day of Cosucra’s native inulin led to increases in Bifidobacteria levels, as could be expected for this prebiotic.
Of particular interest, however, was that levels of calprotectin in the feces decreased after inulin intake. Fecal calprotectin is a marker of gut inflammation.
The researchers, led by Nathalie Delzenne from Université catholique de Louvain in Belgium, also reported that, while no significant changes to fecal short chain fatty acid (SCFA) levels were observed, the inulin group did exhibit increases in fecal rumenic acid, described by the researchers as a